Company / Tangible Book Value per Share
Esperion Therapeutics, Inc. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
-$1.45
FY2025
5-year range
-$7.27 / -$1.45
FY2021-FY2025
Trend
+30.0%
vs FY2024
Sector context
#192 of 209
Health Care
What the data says
Among 209 Health Care companies, Esperion Therapeutics, Inc. is in the bottom 8% for tangible book value per share. Tangible Book Value per Share has increased for 4 consecutive years, from $-7.27 in FY2021 to $-1.45 in FY2025.
Based on SEC 10-K filings.
-1.45 in FY2025.
Improved from $-4.41 to $-1.45 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 209This company -$1.45 Sector average $93.47
▼
-101.6% below sector average
Key checks
Key Insights
- Esperion Therapeutics, Inc.'s tangible book value per share has grown for 4 consecutive years.
- In FY2025, tangible book value per share increased 30.0% year-over-year.
- Ranks #192 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score -1.60 (distress zone, below 1.8 threshold)
- Negative profit margin: -15.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.45 | +30.0% |
| FY2024 | -$2.08 | +52.9% |
| FY2023 | -$4.41 | +9.5% |
| FY2022 | -$4.88 | +32.9% |
| FY2021 | -$7.27 | -107.9% |
| FY2020 | -$3.50 | -570.1% |
| FY2019 | $0.74 | -74.9% |
| FY2018 | $2.96 | -71.1% |
| FY2017 | $10.22 | +0.8% |
| FY2016 | $10.14 | -22.3% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026